National Center for High-performance Computing biomedical team visited National Institutes of Health for joint research

This article is quoted from the newsletter of the Science and Technology Division,Taipei Economic and Cultural Representative Office in the U.S. 

National Cheng Kung University Distinguished Professor Chung Pauchoo Laboratory Team (graduate students Ye Linji and Lin Guanwei) and the NCHC of Narlabs (research fellows Zhuang Chaojun and Chen Yanyun) visited the National Institutes of Health (NIH) in early June for joint research on a federated learning platform. With the assistance of the Science and Technology Division, Taipei Economic and Cultural Representative Office in the U.S., they met with Director Fan Yangzheng of the National Institute Of Neurological Disorders And Stroke on June 14 and 15 and established contacts with personnel at the research centers of the institute.

The biomedical information team of the NCHC of Narlabs and the National Cheng Kung University Distinguished Professor Chung Pauchoo Laboratory Team visited NIH to learn, exchange, and network.

The NCHC of Narlabs, with world-class high-performance computing, network resources and other sound infrastructure, can collaborate with the team of National Cheng Kung University Distinguished Professor Chung Pauchoo on the development of artificial intelligence-related technologies in pathological image analysis of panoramic slides in hopes of establishing a model of academic-research cooperation. This trip to the NIH mainly focused on pathology and AI. Combining NIH's breast cancer pathology imaging data, the federated learning technology developed by Distinguished Professor Chung's team, and the biomedical platform developed by the NCHC, it is hoped to create a cross-border privacy-protecting AI machine learning architecture in the future while at the same time to strengthen the collaboration relationship with the NIH. It is believed that this effort will help Taiwan to promote technological innovation in biomedicine, cultivate talent, and enhance research competitiveness.

(Right) Emily Tai of the National Cancer Institute (NCI) moderates the exchange session. 
(left) Dr. Zhuang Chaojun of the NCHC of Narlabs shows the Biomedical Information Platform service. 


The Science and Technology Division, Taipei Economic and Cultural Representative Office in the U.S. division head Yang Xiuya (3rd from right) and Director Fan yangzheng (4th from right), National Cheng Kung University Distinguished Professor Chung Pauchoo (5th from right), the NCHC of Narlabs Dr. Zhuang Chaojun (4th from left) and delegation members pose for a group photo.

Note:
●The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services (HHS), is the nation’s primary biomedicine research agency. 
●The National Cancer Institute (NCI) is the U.S. federal government's principal agency for cancer research and training and a member institute of the National Institutes of Health (NIH).
●Emil Tai is a research fellow at the National Cancer Institute and also as the contact person and director of the organization of Taiwanese working for the National Cancer Institute.